コンテンツへスキップ
Merck

Triamcinolone acetonide in ocular therapeutics.

Survey of ophthalmology (2007-08-28)
C M Jermak, J T Dellacroce, J Heffez, G A Peyman
要旨

Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinal vasculature disease and uveitis. This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and extraocular. It discusses side effects and their management. Finally, it discusses the controversy over its use.

材料
製品番号
ブランド
製品内容

USP
トリアムシノロンアセトニド, United States Pharmacopeia (USP) Reference Standard
Supelco
トリアムシノロンアセトニド, analytical standard
トリアムシノロンアセトニド, European Pharmacopoeia (EP) Reference Standard
システム適合性用トリアムシノロンアセトニド, European Pharmacopoeia (EP) Reference Standard